Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abrdn Total Dynamic Dividend Fund | AOD | Nov 27, 2024 | 8.70 | +0.23 |
Abrdn World Healthcare Fund Shares Of Beneficial Interest | THW | Nov 27, 2024 | 12.08 | +0.67 |
Absci | ABSI | Nov 27, 2024 | 2.94 | +6.91 |
ABVC Biopharma | ABVC | Nov 27, 2024 | 0.51 | +0.83 |
Ac Immune SA | ACIU | Nov 27, 2024 | 3.36 | -1.18 |
Acacia Research | ACTG | Nov 27, 2024 | 4.49 | -0.22 |
Academy Sports and Outdoors | ASO | Nov 27, 2024 | 48.85 | +1.75 |
Acadia Healthcare | ACHC | Nov 27, 2024 | 41.28 | +0.61 |
Acadia Pharmaceuticals | ACAD | Nov 27, 2024 | 16.29 | +0.49 |
Acadia Realty Trust | AKR | Nov 27, 2024 | 26.08 | +1.76 |
Acasti Pharma, Inc. | ACST | Nov 27, 2024 | 3.37 | 0.00 |
Accel Entertainment | ACEL | Nov 27, 2024 | 11.60 | -1.53 |
Accelerate Diagnostics | AXDX | Nov 27, 2024 | 1.61 | -2.42 |
Accenture A | ACN | Nov 27, 2024 | 362.16 | -0.28 |
Acco Brands | ACCO | Nov 27, 2024 | 5.81 | -0.85 |
Accolade | ACCD | Nov 27, 2024 | 3.75 | -0.53 |
Accuray | ARAY | Nov 27, 2024 | 2.11 | +7.65 |
Acelyrin | SLRN | Nov 27, 2024 | 4.57 | -1.51 |
Achieve Life Sciences | ACHV | Nov 27, 2024 | 4.49 | +0.22 |
Achilles Therapeutics ADR | ACHL | Nov 27, 2024 | 1.07 | -0.14 |
ACI Worldwide | ACIW | Nov 27, 2024 | 56.66 | -1.12 |
Aclarion | ACON | Nov 27, 2024 | 0.18 | -2.21 |
Aclaris Therapeutics | ACRS | Nov 27, 2024 | 3.82 | +5.23 |
ACM Research A | ACMR | Nov 27, 2024 | 17.27 | -0.58 |
Acme United | ACU | Nov 27, 2024 | 44.35 | +0.77 |
ACNB | ACNB | Nov 27, 2024 | 46.96 | +0.32 |
ACRES Commercial Realty | ACR | Nov 27, 2024 | 17.36 | +0.12 |
ACRES Commercial Realty C Pref | ACR-C | Nov 27, 2024 | 25.10 | +0.04 |
ACRES Commercial Realty D Pref | ACR-D | Nov 27, 2024 | 22.76 | +1.61 |
Acrivon Therapeutics | ACRV | Nov 27, 2024 | 7.52 | +2.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.